Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: RAMM Pharma Corp.

Market Cap 1.79M 1.26M 1.1M 1.02M 954K 119M 1.8M 12.15M 4.73M 58.75M 4.75M 4.64M 204M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 1.07M 754K 659K 609K 569K 71.22M 1.08M 7.24M 2.82M 35.02M 2.83M 2.77M 122M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
6 months-62.50%
Current year-75.00%
1 month 0.01
Extreme 0.01
0.02
Current year 0.01
Extreme 0.01
0.05
1 year 0.01
Extreme 0.01
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
1
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 08/12/2022
Director TitleAgeSince
Director/Board Member - 30/09/2019
Director/Board Member 82 30/09/2019
Director/Board Member 66 30/09/2019
Date Insider Type Main position Quantity % Market Cap.
01/06/25Sell

Chief Executive Officer

4,667,000 3.9091%
20/03/25Buy

Chief Executive Officer

200,000 0.1675%
20/03/25Buy

Chief Executive Officer

100,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-70.00% 1.26M
+0.32%-2.73%+44.49%+143.28% 980B
+1.27%-3.98%+54.41%+41.13% 550B
+6.25%+1.00%+24.13%+68.06% 382B
-0.06%-3.09%+23.33%+16.78% 316B
+0.42%-1.28%+27.89%+14.71% 272B
+1.67%-1.47%+26.76%+32.88% 268B
+2.39%+4.42%-36.96%-45.12% 199B
+2.11%-2.95%+19.14%+51.83% 182B
+0.90%-0.57%+15.09%+60.89% 154B
Average +1.54%-2.43%+24.83%+31.44% 330.23B
Weighted average by Cap. +1.52%-3.50%+31.28%+65.69%

Financials

2024 2025
Net sales 4.34M 3.07M 2.68M 2.48M 2.31M 290M 4.37M 29.45M 11.46M 142M 11.51M 11.26M 495M 3.36M 2.37M 2.07M 1.92M 1.79M 224M 3.39M 22.79M 8.87M 110M 8.91M 8.72M 383M
Net income -16.5M -11.65M -10.18M -9.42M -8.79M -1.1B -16.62M -112M -43.55M -541M -43.75M -42.8M -1.88B -8.91M -6.29M -5.5M -5.09M -4.75M -595M -8.98M -60.43M -23.51M -292M -23.62M -23.11M -1.02B
Net Debt -626K -442K -386K -357K -333K -41.75M -630K -4.24M -1.65M -20.53M -1.66M -1.62M -71.32M -723K -511K -446K -413K -385K -48.28M -729K -4.91M -1.91M -23.74M -1.92M -1.88M -82.46M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
  1. Stock Market
  2. Stocks
  3. RAMM Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!